The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike subcutaneous injections, this technique offers a less invasive way to deliver https://robertcxrz987300.isblog.net/glp-1-patches-a-new-approach-to-glucose-treatment-58271713